"10.1371_journal.ppat.1003643","plos pathogens","2013-09-26T00:00:00Z","Emmanuel A Asante; Jacqueline M Linehan; Michelle Smidak; Andrew Tomlinson; Andrew Grimshaw; Asif Jeelani; Tatiana Jakubcova; Shyma Hamdan; Caroline Powell; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge","Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, United Kingdom","Conceived and designed the experiments: EAA JDFW JC. Performed the experiments: EAA JML MS AT AG AJ TJ SH CP SB. Analyzed the data: EAA MS SB JDFW JC. Contributed reagents/materials/analysis tools: EAA JDFW SB JC. Wrote the paper: EAA JDFW JC.","JC and JW are shareholders and JC is a director of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen markets one of the routine antibodies (ICSM 35) used in this study. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.","2013","09","Emmanuel A Asante","EAA",12,TRUE,3,10,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
